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Highlights 10 
 Three novel Amurin-2 variants were identified from the skin secretion of Rana amurensis. 11 
 Cationic-enhanced analogues show broader antimicrobial activity spectrums. 12 
 The substitution by Lys at position 4 improves the antimicrobial selectivity on E. coli. 13 
 The cell lysis ability of Amurin-2 peptides is associated with their positive charge. 14 
 15 
Abstract1: Rana amurensis is important in Chinese medicine as its skin secretions contain abundant bioactive 16 
peptides. Here, we have identified the antimicrobial peptide Amurin-2 and three highly-conserved variants, 17 
Amurin-2a, Amurin-2b and Amurin-2c through a combination of molecular cloning and MS/MS fragmentation 18 
sequencing. Synthetic replicates of these peptides demonstrate potent antimicrobial activity against S. aureus, 19 
whilst some have activity against C.albicans and even resistant bacterial MRSA. Furthermore, two Lys-20 
analogues (K4-Amurin-2 and K11-Amurin-2) were designed to improve the bioactive function and the 21 
antimicrobial activity of K4-Amurin-2 against E.coli was enhanced distinctly. In addition, the two modified 22 
peptides also showed more potent activity against S. aureus, C. albicans and MRSA strains. Meanwhile, these 23 
peptides showed inhibitory effect on the cell viability of several cancer cells. As a result, these structural and 24 
functional studies of Amurin-2 variants and analogues could provide insights for future antimicrobial peptide 25 
design. 26 
Keywords: antimicrobial peptide; amphibian skin secretion; cationicity-related peptide design. 27 
Introduction 28 
Antimicrobial peptides (AMPs) are abundant in amphibian skin secretions, with more than 300 disparate 29 
kinds of AMPs having been discovered already from frog species [1]. In particular, numerous AMP families with 30 
various functions have been discovered from frogs of the Ranidae family in recent years. The peptides in the skin 31 
secretions of frogs mainly help them to defend against microorganisms they come into contact with and it is 32 
common for close species to have AMP families with highly conserved coding sequences within their signal 33 
peptides, but diverse sequences within the pro-peptides.  A series of peptide variants of the same AMP family can 34 
be isolated from one frog species. The hyper-mutations of frog-derived peptides can be induced by environmental 35 
or bacterial challenges [5] and these variants can be retained owing to their survival value in natural selection. 36 
Examples of this include six peptides (Brevinin-1Ba~f) from the Brevinin subfamily isolated from the skin of 37 
Lithobates berlandieri [2] and ten Temporins isolated from the skin of Rana temporaria [3]. These AMP variants 38 
produced by the same species can act together to enhance their combined antimicrobial activity, something 39 
demonstrated via the studies of Temporin A, B with L on gram positive strains [4, 5]. Additionally, variants of 40 
                                                            
1 Abbreviations：AMP, antimicrobial peptide; MRSA, methicillin-resistant Staphylococcus aureus; HDPs, host-
defence peptides; CD, circular dichroism; MHB, Mueller-Hinton Broth; MIC, minimum inhibitory concentration; 
FBS, foetal bovine serum; MTT, 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide; UTR, 
untranslated region; HC50, half haemolytic concentrations; IC50, half maximal inhibitory concentration;  
one AMP can be distributed in closely related frog species [6], such as the Brevinins which have been isolated 41 
from the Rana genus and Dermaseptins from the Phyllomedusa genus [7, 8].   42 
In this report, we have identified four wild-type peptides (Amurin-2, Amurin-2a, Amurin-2b and Amurin-43 
2c) of the Amurin family from the skin secretions of the Heilongjiang brown frog, Rana amurensis. Through a 44 
multi-sequence alignment we have shown that the nucleotide sequences of the four precursor peptides show a 45 
high degree of similarity. The mature Amurin-2c has the same amino acid sequence as Brevinin-2CDYc which 46 
was isolated from Rana dybowskii. In addition, two peptide analogues were synthesized to study the functional 47 
rules of Amurin-2 variants on microorganisms. Even though the mature peptides are highly similar, we have found 48 
these six peptides show different antimicrobial and anti-proliferative potencies.  49 
Materials and Methods  50 
Rana amurensis Skin Secretion Harvesting  51 
The Rana amurensis frog specimens, which were all adults, were derived from the Jilin province of the 52 
Peoples Republic of China. The skin secretions of four Rana amurensis frog specimens were obtained as described 53 
previously [9].  54 
‘Shot gun’ Cloning of Amurin-2 variants precursor-encoding cDNAs 55 
The molecular cloning was carried out as described previously [9]. The isolated mRNA was subjected to the 56 
3’-RACE procedures using a degenerate primer (S1; 5′-GAWYYAYYHRAGCCYAAADATG-3′, W=A+T; 57 
Y=T+C; H=A+C+T; R=A+G; D=A+G+T) that was designed to a highly-conserved domain of the 50-untranslated 58 
region of previously characterized peptide precursor cDNAs from closely-related Rana species.  59 
Identification and structural analysis of Amurin-2 variants 60 
The supernatant of centrifuged skin secretion was decanted and pumped directly onto an analytical reverse 61 
phase HPLC column (Phenomenex C-18, 25 cm × 0.45 cm) that was attached to a Cecil CE4200 Adept gradient 62 
reverse phase HPLC system (Cecil Instruments Limited, Cambridge, UK). Peptides were eluted using a gradient 63 
formed from 0.05/99.5 (v/v) TFA/water to 0.05/19.95/80.0 (v/v/v) TFA/water/acetonitrile in 240 min at a flow 64 
rate of 1 ml/min directly into a Thermo Fisher Scientific LCQ Fleet electrospray ion-trap mass spectrometer in 65 
positive detection mode. By means of data-dependent acquisition, doubly charged peptide ions detected in the 66 
mass spectrometer were automatically subjected to MS/MS fragmentation.  67 
Syntheses of Amurin-2 variants and the Lys-analogues 68 
Amurin-2, Amurin-2a, Amurin-2b, Amurin-2c, K4-Amurin-2 and K11-Amurin-2 were synthesized by solid-69 
phase Fmoc chemistry using a Tribute® Peptide Synthesizer (Protein Technologies, Tucson, AZ, USA).The Fmoc 70 
protection groups were removed by 20/80 (v/v) Piperidine/dimethylformamide and the peptide bond was coupled 71 
in the presence of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), dissolving 72 
in 11/89 (v/v) N-methylmorpholine/dimethylformamide. Following cleavage from the resin and deprotection by 73 
a reaction containing 2/2/2/94 (v/v/v/v) 1,2-ethanedithiol/H2O/thioanisole/TFA for 2 h at room temperature. The 74 
peptide was washed using diethyl ether and dissolved in 0.05/99.95 (v/v) TFA/water. A final concentration of 75 
0.01% of H2O2 was added to perform the formation of the disulphide bond.  76 
Secondary structural analyses of Amurin-2 variants and the Lys-analogues through circular dichroism 77 
(CD) spectroscopy 78 
The sample peptide solutions (50 μM) were prepared in 10 mM ammonium acetate initially in a 1 mm high 79 
precision quartz cell (Hellma Analytics, Essex, UK). CD measurements were performed at room temperature by 80 
a JASCO J-815 CD spectrometer (Jasco, Essex, UK) across the wavelength range from 190 nm-250 nm. The 81 
scanning speed was 100 nm/min, the bandwidth was 1 nm and the data pitch was 0.5 nm. 82 
Antimicrobial susceptibility tests of Amurin-2 variants and the Lys-analogues 83 
The antimicrobial susceptibility tests of Amurin-2 variants were performed on Staphylococcus aureus (G+ 84 
bacteria, NCTC 10788), Escherichia coli (G- bacteria, NCTC 10418), Candida albicans (yeast, NCPF 1467) and 85 
MRSA (Methicillin-resistant Staphylococcus aureus, ATCC 12493). These microorganisms were grown in 86 
Mueller-Hinton Broth (Oxoid, Basingstoke, Hampshire, UK) (MHB) at 37 °C. The MIC values were tested as in 87 
our previous study [9]. 88 
Cell viability test of Amurin-2 variants and the Lys-analogues on cell lines 89 
The cancer cell lines H157 (ATCC-CRL-5802, ATCC, Teddington, Middlesex, UK) and PC-3 (ATCC-CRL-90 
1435) were cultured in RPMI-1640 culture medium (Invitrogen, Paisley, UK) containing 10% FBS and 1% 91 
Penicillin-Streptomycin. The cancer cell lines U251MG (ECACC-09063001, ECACC, Salisbury, UK), MDA-92 
MB-435s (ATCC-HTB-129) and MCF-7 (ATCC-HTB-22) were cultured in RPMI-1640 culture medium 93 
(Invitrogen, Paisley, UK) containing 10% FBS and 1% Penicillin-Streptomycin.  The normal cell line HMEC-1 94 
(ATCC-CRL-3243) was cultured in MCDB131 medium (Gibco, Paisley, UK) containing 10% FBS, 10 ng/ml 95 
epidermal growth factor (EGF), 1 µg/mL hydrocortisone, 10 mM Glutamine and 1% penicillin streptomycin to 96 
test the toxicity of peptides on normal cells. The cell viability test using MTT was performed as described 97 
previously [9]. 98 
Haemolytic activity test of Amurin-2 variants and the Lys-analogues 99 
The haemolytic activity test was performed using completely washed horse erythrocytes (TCS Biosciences 100 
Ltd., Buckingham, UK) and carried out as previously described [9]. 1% of Triton X-100 (Sigma-Aldrich, St. 101 
Louis, MO, USA) was used as the positive control. The absorbance measured by a Synergy HT plate reader 102 
(BioTek Instruments, Inc., Winooski, VT, USA) at 550 nm.  103 
Results 104 
Precursor-encoding cDNA of Amurin-2 variants from the skin secretions of Rana amurensis 105 
From the skin secretion cDNA library, four highly-conserved sequences were obtained using the same 106 
degenerate primer (Figure S1). One of four sequences isolated is identical to the previously identified cDNA of 107 
the Amurin-2 precursor [10]. The topological structures of the four precursors contain several domains including 108 
a signal peptide containing 22 amino acids, a 23-mer acidic spacer peptide, a typical -KR- convertase processing 109 
site and the mature peptide domain. Due to the high degree of similarity between these four cDNAs (Figure 1), 110 
we named the other three variants as Amurin-2a, Amurin-2b and Amurin-2c, respectively. 111 
Isolation of Amurin-2 and variants from the skin secretion of the Rana amurensis 112 
The skin secretion of Rana amurensis was successfully fractionated within 240 min under the linear gradient. 113 
The presence of Amurin-2 and variants were confirmed and the primary structures are consistent with the cDNA 114 
encoding mature peptide (Table 1). Amurin-2 and the variants were eluted at 40%-50% ACN and indicated in the 115 
chromatography (Figure 2). The MS/MS analysis showed that Amurin-2a and Amurin-2b were co-eluted at about 116 
126 min; Amurin-2 and Amurin-2c were eluted at about 122 min and 119 min respectively.  117 
Physio-chemical properties of synthetic natural peptides and two Lys-substituted analogues 118 
Four natural peptides were synthesized and purified and the charge and hydrophobicity were calculated 119 
(Table 1). The helical wheel projects showed that Amurin-2 and Amurin-2c have one more positive charge on the 120 
hydrophilic phase than Amurin-2a and Amurin-2b. Two Lysine-substituted analogues (K4-Amurin-2 and K11-121 
Amurin-2) were designed based on Amurin-2a due to its slight haemolytic activity. The positive charge on the 122 
hydrophilic phase of the two analogues were enhanced while K4-Amurin-2 showed a large hydrophilic surface 123 
(Figure 3A). The CD spectra (Figure 3B) indicated that all peptides formed typical α-helix structure in the 124 
membrane-mimic environment. The calculated helicities of all peptides are also shown in table 1. 125 
Antimicrobial and Haemolysis Activity of Amurin-2 variants and analogues 126 
To examine the antimicrobial properties of the different peptides we identified their minimum inhibitory 127 
concentrations (MICs) against a number of representative microorganisms. Generally, these peptides showed 128 
more potent effects against wild-type S. aureus when compared to the other microorganisms and MRSA (Table 129 
2). Amurin-2a and Amurin-2b only inhibited the growth of S. aureus, as well as exhibiting lower haemolysis. The 130 
two modified peptides (K4-Amurin-2, K11-Amurin-2) demonstrated markedly enhanced activity against all the 131 
microorganisms, but also showed enhanced haemolytic activity. K4-Amurin-2 even had significant activity against 132 
E. coli. A summary of the MICs and half haemolytic concentrations of all the peptides are shown in Table 2. 133 
Cell viability test of Amurin-2 variants and analogues   134 
To determine if these peptides also had anti-proliferative activity against human cancer cells we next 135 
examined their impact upon a range of cancer and normal cells. All peptides exhibited broad-spectrum activity 136 
against the cell viability of tested cancer cell lines as well as the normal cell line, HMEC-1 (Figure 4), and the 137 
corresponding IC50 are listed in Table 3. Amurin-2 and Amuin-2c show more potent effect than the others. By 138 
contrast, Amurin-2a and Amurin-2b have less potent effects on the viability of H157 and MB435 cells at the 139 
highest concentrations.  140 
Discussion 141 
In a previous study we identified Amurin-2 from the dried skin extraction of Rana amurensis [10]. Here, a 142 
further three Amurin-2 variants were isolated from the skin secretion of the same frog species. The observation 143 
of multiple AMP variants has previously been reported in species from Ranidae family [2, 3] and although there 144 
is no clear explanation for the co-expression of such peptide variants, it was speculated that these different variants 145 
are present as they provide broader spectrum antimicrobial activity and so form part of  a unique survival strategy 146 
to protect these species of frog [11]. The Amurin-2 variants are highly similar to Brevinin-1CDYb from the skin 147 
secretions of the Dybowski's frog [12, 13]. Rana amurensis (2n=26) and Rana dybowskii (2n=24) are not closely 148 
related and their genomes consist of different numbers of chromosomes, further indicating their relatively distant 149 
taxonomic relationship (D=1.177). However, the conservation of the cDNA sequences of Amurin-2 and Brevinin-150 
1CDYb (Identity=86.5%) [14] indicates these AMPs have been maintained due to their importance in the 151 
antimicrobial defence of these different species.  152 
Although the Amurin-2 variants isolated here are structurally conserved, their biological activities were 153 
markedly different. In particular, Amurin-2 and Amurin-2c showed potent activity against C.albicans and MRSA 154 
but Amurin-2a and Amurin-2b showed little activity against these strains. It has been speculated that positive 155 
charges at the hydrophilic phase can remarkably enhance the initial electrostatic interaction between peptides and 156 
negatively-charged cell membranes [6]. Therefore the observation that the haemolytic activates of Amurin-2a and 157 
Amurin-2b are less potent than the others was consistent with the lower charge which they exhibit. In addition, 158 
Amurin-2b is slightly more potent than Amurin-2a, indicating that its larger proportion of hydrophilic surface 159 
could enhance its activity, but the impact of this is lower than that produced by difference in cationicity. Indeed, 160 
some studies have indicated that AMPs with an uninterrupted hydrophobic residue region show less haemolysis, 161 
whilst maintaining antimicrobial activity [15].  162 
When compared to Amurin-2a, the electro-positivity of the hydrophilic phases of the two modified peptides, 163 
K4-Amurin-2 and K11-Amurin-2, were increased and thus the antimicrobial and haemolytic activities were 164 
enhanced significantly. Indeed, K4-Amurin-2 even demonstrated potent activity against E. coli. In regards to their 165 
helical structure, we would assume that the composition of the hydrophilic surface of the Amurin peptides 166 
significantly influences their biological activity. The more cationic they are on their hydrophilic surface, the more 167 
potent the membrane interaction, which should increase their antimicrobial, haemolytic and cytotoxic activity. In 168 
addition, K4-Amurin-2 is the only peptide  with activity against E. coli (MIC=16 μM), and the substitution of Leu4 169 
with Lys4 at the hydrophilic phase increases the amphipathcity of the peptide. The stronger amphipathic activity 170 
of K4-Amurin-2 probably allows it to pass through the dense cell wall of E. coli directly. Indeed, the outer-171 
membrane of E. coli cells are mainly composed of amphipathic lipopolysaccharides, whilst the cell wall of S. 172 
aureus is constituted mainly of electro-negative peptidoglycans. In addition, a previous study of Magainin 173 
analogues indicates relatively high hydrophobic moment will directly increase membrane binding and the 174 
permeabilisation [16].  175 
Conversely, the Amurin-2a and Amurin-2b have the similar hydrophobic surface as the other peptides, but 176 
one positive charge less. The observation of the lower haemolytic activities of Amurin-2a and Amurin-2b indicates 177 
the ability of cell lysis of these peptides is correlated with their cationicity, which have been considered as 178 
emphases in the sequence designing [17, 18]. In addition, the proline residue, which is known to make a hinge as 179 
a helix breaker, the presence of proline at position 3 decreases the haemolytic activity of two modified analogues 180 
when comparing to Amurin-2 and Amurin-2c, indicating that the helical kink is related to the selectivity of Amurin 181 
peptides [19]. Although, the Lys substituted at position 4 increases the amphipathcity that improve the 182 
permeabilisation of E. coli cells, it remains the same haemolysis with K11-Amurin-2. The charge induced at 183 
position 4 enhances the selectivity on E. coli instead of non-specific permeability. The reason is not clear so for, 184 
but we assume that might be related to the N-terminal hinge region which could help to expose the positive charge 185 
to the negatively-charged LPS and dig into the internal region of E. coli cell envelope.  186 
Generally, α-helical domain is also associated with the bioactivity of AMPs [16], but in this study, the CD 187 
results showed unclear correlation between peptide activity and α-helical domain. It is speculated that the function 188 
is more related to the distribution of amino acids residue on the surface of α-helical structure rather than the helix 189 
proportion itself. The anti-cancer activity of the six peptides is similar to their haemolytic functions and this may 190 
be due to their impact upon mammalian cell membranes which have similar lipid compositions [20]. However, 191 
K11-Amurin-2 showed a lower activity against MCF-7 cells. The reason for this is not clear but possibly the 192 
substitution of Ser11 with Lys11 may somehow influence the targeting of this peptide to MCF-7 cells. 193 
In summary, three Amurin-2 variants were identified from the skin secretion of Rana amurensis and two 194 
Lys-analogues were designed to perform a structure-activity study. Basically, increasing the net positive charges 195 
of Amurin peptides could improve the antimicrobial activity as well as the haemolytic activity. But the proline-196 
related kink conformation is helpful to reduce the haemolytic activity. The substitution by positively-charged Lys 197 
at positive 4 can enhance the selectivity on E. coli, however, the reason needs to be further investigated.  198 
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Legends to Figures  258 
Figure 1. The alignment of full length nucleotide sequences (A) and translated open reading frame sequences (B) 259 
of the four Amurin-2 variants. Each of the cDNAs contain 310 base pairs encoding 67 amino acids. The identical 260 
nucleotidesand amino acid residues are highlighted. 261 
Figure 2. The chromatography of the skin secretion of Rana amurensis. The elution positions/retention times of 262 
Amurin-2 and the variants were indicated by arrows. 263 
Figure 3. Physio-chemical properties of synthetic natural peptides and two Lys-substituted analogues. (A) Helical 264 
wheel projections of Amurin-2 variants and analogues. The directions of hydrophobic moments of peptides are 265 
denoted by the arrows in the middle of the wheels. (B) CD Spectrum of Amurin-2 variants and two analogues in 266 
0.5/0.5 (v/v) NH4AC/TFE. 267 
Figure 4. Cell viabilities of cancer cell lines (H157, PC-3, U251MG, MB435s and MCF-7) and normal cell line 268 
(HMEC-1) with different concentrations (10-9 to 10-4 M) of Amurin-2 variants and analogues.  269 
  270 
 271 
Tables 272 
Table 1. The structure and physio-chemical properties of Amurin-2 variants and analogues. The bold typeface 273 
indicates the substituted Lys in the sequences. 274 
Peptide Sequence Hydrophobicity <H> Net charge  α-helix) 
Amurin-2 FLSLALAALPKLFCLIFKKC 0.955 3 42% 
Amurin-2a FLPLLLAGLPSFLCLVFKKC 1.065 2 69% 
Amurin-2b FLPLLLSALPSFLCLVFKKC 1.063 2 59% 
Amurin-2c FLSLALAALPKFLCLVFKKC 0.925 3 30% 
K4-Amurin-2 FLPKLLAGLPSFLCLVFKKC 0.930 3 43% 
K11-Amurin-2 FLPLLLAGLPKFLCLVFKKC 1.017 3 61% 
 275 
Table 2. The minimum inhibitory concentrations (MICs, μM) and half haemolytic concentrations (HC50, μM) of 276 
Amurin-2 variants and analogues. 277 
 MIC (μM) HC50 (μM) 1 
S. aureus E. coli C. albicans MRSA 
Amurin-2 32  >512 32 32 4.7 
Amurin-2a 128 >512 >512 >512 439.0 
Amurin-2b 32 >512 >512 512  195.9 
Amurin-2c 32 >512 32 32 17.0 
K4-Amurin-2  16 16 8 8 31.0 
K11-Amurin-2 16 512 16 16 29.1 
1 The half haemolytic concentrations (HC50, μM) were analysed by Graphpad Prism Software. 278 
 279 
Table 3. IC50 (μM) of Amurin-2 variants and analogues on cancer cell lines and HMEC-1 cell line. 280 
 IC50 (μM) H157 PC-3 U251MG MB435S MCF-7 HMEC-1 
Amurin-2 4.5  6.4  4.6 9.5 9.1 25.2 
Amurin-2a 60.2 133.6 86.42 193.3 302.1 1545 
Amurin-2b 77.5 300.9 144.3 780.0 498.4 180.8 
Amurin-2c 10.6 7.0 4.1 10.3 14.6 35.9 
K4-Amurin-2 8.2 28.4 14.8 19.6 41.6 85.2 
K11-Amurin-2 6.9 16.0 9.2 58.1 310.6 52.1 
 281 
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